Stocks · Health care · Biological Products, (No Diagnostic Substances)

Passage BIO, Inc.

PASG Clue Score25
United States Fiscal year ends December CIK 0001787297 Results filed 3 Mar 2026

What the insiders did Net buying

By person

4 insiders · 3 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Lynx1 Capital Management LP entity
10% owner
$206.10K (1)
—
+$206.10K
673,759
$2.77M
—
William Chou
President and CEO
—
$75.16K (1) scheduled
−$75.16K
6,524
$26.86K
+987.3%
Kathleen Borthwick
CFO
—
$38.02K (1) scheduled
−$38.02K
5,402
$22.24K
—
Orbimed Advisors LLC entity
10% owner
—
—
—
6,066,343
$24.98M
−22.2%

No percentages here. This company's share count has moved by a factor of 19.6 over the window, from 3,178,710 to 62,148,274 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.